4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001179110-11-013877
Options or other derivatives
- Director acquired 155,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
STALDER RUEDI · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2011-09-30 | Grant or award : show line 1 in the form Common Stock | +155,000 | $0.23 | 2021-09-30 | 155,000 | 1,316,787 | D |
Loading xslF345X03/edgar.xml…